Hara, Noboru <br/><br/>
Insulin-like growth factor-1 is associated with regulation of the luteinizing hormone production in men receiving androgen deprivation therapy with gonadotropin-releasing hormone analogues for localized prostate cancer.  [electronic resource] 

 -  Urologic oncology  Sep 2012 
 - 596-601 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1873-2496 
<br/><br/><label>Standard No.: </label>10.1016/j.urolonc.2010.11.001  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adrenocorticotropic Hormone--blood<br/>Aged<br/>Androgen Antagonists--administration & dosage<br/>Antineoplastic Agents, Hormonal--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Dehydroepiandrosterone Sulfate--blood<br/>Flutamide--administration & dosage<br/>Goserelin--administration & dosage<br/>Human Growth Hormone--blood<br/>Humans<br/>Immunoassay--methods<br/>Insulin-Like Growth Factor I--metabolism<br/>Logistic Models<br/>Luteinizing Hormone--blood<br/>Male<br/>Middle Aged<br/>Multivariate Analysis<br/>Outcome Assessment, Health Care<br/>Prospective Studies<br/>Prostate-Specific Antigen--blood<br/>Prostatic Neoplasms--blood<br/>Testosterone--blood